Research in Radiation Oncology

Research in Radiation Oncology

The research mission of the Department of Radiation Oncology at Penn State College of Medicine and Penn State Cancer Institute spans innovation and discovery through translational and investigator-initiated studies and multi-center cooperative group clinical trials. The department's researchers have been at the forefront of engineering in medicine including the development of new radiopharmaceuticals and magnetic resonance guided radiotherapy with multiple patents and peer-reviewed articles related to these exciting new technologies. The department also has an incredibly strong track record of successful collaboration with industry partners on technology development through NIH Academic-to-Industry as well as STTR/SBIR mechanisms.

Furthermore, this dynamic team of clinician investigators has a history of bridging the bench to bedside with numerous phase I clinical trials exploring new drug/radiotherapy combinations and new radiotherapy delivery and fractionation schemes.

Finally, multiple investigators hold leadership roles and serve as national principal investigators at NRG Oncology and ECOG-ACRIN Cooperative Groups for multi-center prospective clinical trials through the National Cancer Institute. The department especially prides itself on mentorship of the next generation of physicians, medical physicists and engineers leading in radiation oncology.